Dr. Vijay Palwe

Introduction

Expertise

• Dr. Vijay’s expertise lies in the management of all types of malignant and benign tumours and oncological emergencies.
• He is well trained in conventional, 3DCRT, IMRT and IGRT based treatments, with a special interest in head and neck cancers, breast cancers and gynaecological cancers, brachytherapy (head & neck, breast, soft tissue sarcoma, cervix, vault), 3DCRT, IMRT, IGRT and palliative Care. He is also an expert in delivering intraluminal RT for esophagus cancer.

Training and Certifications

• Dr. Vijay has completed his certification courses in clinical research methodology and cardiopulmonary resuscitation.

Recognition

• Dr. Vijay is also a recipient of various awards at both, international and national levels.
• He has served as a sub-investigator for various clinical trials.
• Dr. Vijay has presented his research at numerous national and international conferences.

Publications

• Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
• Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial (2019). Oncotarget, 10(54), 5605.
• The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity (2021). European Archives of Oto-Rhino-Laryngology, 1-9.
• Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
• Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021). European Journal of Breast Health, 17(1), 62.

Other Doctors